Related Experiment Videos
Potential clinical applications of interleukin-12
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Current Opinion in Hematology
|May 1, 1996
Summary
Interleukin-12 (IL-12) shows promise in treating infectious diseases and cancer by modulating immune responses. Careful administration is needed to balance its therapeutic potential with toxicity risks.
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Interleukin-12 (IL-12) is a key cytokine influencing cellular immunity.
- IL-12 has demonstrated potential in managing infectious diseases and cancer.
- Its role as an adjuvant in inducing immune responses is recognized.
Purpose of the Study:
- To explore the therapeutic potential of Interleukin-12 (IL-12) in various pathologies.
- To evaluate IL-12's efficacy as an immune response modulator and adjuvant.
- To address the challenges of IL-12's toxicity and regulation for clinical application.
Main Methods:
- Review of existing literature on IL-12's biological activities.
- Analysis of preclinical data from animal models of infectious diseases and tumors.
- In vitro studies on human pathologies involving IL-12.
Main Results:
- IL-12 exhibits potent effects on immune cell development and differentiation.
- Demonstrated efficacy in animal models for intracellular pathogens and tumors.
- Potential as an adjuvant for protective immune responses in various models.
Conclusions:
- Interleukin-12 (IL-12) holds significant therapeutic promise for infectious diseases and cancer.
- Clinical application requires careful consideration of toxicity and complex regulation.
- Optimizing IL-12 delivery to target sites is crucial for maximizing therapeutic benefits while minimizing adverse effects.